STX-0812

N/A

Report date: 2024/12/25 16:45:44

Base Information

Drug NameSTX-0812
Drug Alias NameSTX-0812
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-C chemokine receptor type 2 modulators
TargetsC-C chemokine receptor type 2
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSolu Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesSolu Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A